Emerging biotech oncology company. Safety and efficacy evidence in cancer patients, Phase 2 study underway. Potential benefit for many cancer types.
Joined December 2019
- Tweets 701
- Following 239
- Followers 229
- Likes 50
635 Photos and videos
Emerging biotech oncology company. Safety and efficacy evidence in cancer patients, Phase 2 study underway. Potential benefit for many cancer types.